MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher, D, Klec, C, Pasculli, B, Cerk, S, Rinner, B, Karbiener, M, Ivan, C, Barbano, R, Ling, H, Wulf-Goldenberg, A, Stanzer, S, Rinnerthaler, G, Stoeger, H, Bauernhofer, T, Haybaeck, J, Hoefler, G, Jahn, SW, Parrella, P, Calin, GA, Pichler, M.

https://www.ncbi.nlm.nih.gov/pubmed/30709367